Fundraising Fox
🦊/Companies
Sign in

Lumen

Seattle, US · 2 known investors

Find your way into Lumen

Lumen develops orally delivered antibody drugs using engineered spirulina, a patented biologic platform that reduces manufacturing costs and timelines compared to conventional biologics. The company serves biopharma customers seeking alternatives to traditional drug manufacturing.

BiotechDeep TechHealthtechMedical Devices

Founders & leadership

BFBrian Finrow
Brian FinrowinFounder

Investors · 2

WestRiver Group✓ verifiedIssaquah
Samsara BioCapital✓ verifiedPalo Alto

In the news

Lumen Technologies (LUMN) Expands Multi Cloud Access, Is The Undervaluation Case Convincing?finance.yahoo.com · Aug 2026Brigade Capital Management LP Makes New Investment in Lumen Technologies, Inc. $LUMNmarketbeat.com · Aug 2026Lumen Orbit raises more than $10m for AI training data centers in space - DCDdatacenterdynamics.com · Jun 2026TD Cowen Raises Lumen (LUMN) Price Target, Keeps Hold Ratingfinance.yahoo.com · May 2026Lumen - Lumen Renews Signature Teachers & Technology Grant Program with $1 Million for Classroom Innovationir.lumen.com · Dec 2025

Frequently asked questions

What does Lumen do?
Lumen develops orally delivered antibody drugs using engineered spirulina, a patented biologic platform that reduces manufacturing costs and timelines compared to conventional biologics. The company serves biopharma customers seeking alternatives to traditional drug manufacturing.
Who founded Lumen?
Lumen was founded by Brian Finrow.
Who are Lumen's investors?
Lumen's investors include WestRiver Group, Samsara BioCapital.
Where is Lumen headquartered?
Lumen is headquartered in Seattle, US.